Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2010; 104(03): 421-423
DOI: 10.1160/TH10-07-0485
DOI: 10.1160/TH10-07-0485
Theme Issue Editorial
New horizons in vascular biology and thrombosis: Highlights from EMVBM 2009
Further Information
Publication History
Received:
27 July 2010
Accepted:
27 July 2010
Publication Date:
23 November 2017 (online)
-
References
- 1 Furie B, Furie BC. Mechanisms of thrombus formation. New Engl J Med 2008; 359: 938-949.
- 2 Ruggeri ZM. Von Willebrand factor: looking back and looking forward. Thromb Haemost 2007; 98: 55-62.
- 3 Lenting PJ. et al. Regulation of von Willebrand factor-platelet interactions. Thromb Haemost 2010; 104: 449-455.
- 4 Gomez K, McVey JH. Tissue factor initiated blood coagulation. Front Biosci 2006; 11: 1349-1359.
- 5 Owens 3rd AP, Mackman N. Tissue factor and thrombosis: The clot starts here. Thromb Haemost 2010; 104: 432-439.
- 6 Kretz CA. et al. Tissue factor and thrombosis models. Arterioscler Thromb Vasc Biol 2010; 30: 900-908.
- 7 Mackman N. The many faces of tissue factor. J Thromb Haemost 2009; 7 (Suppl. 01) 136-139.
- 8 Ratajczak J. et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20: 1487-1495.
- 9 Mause SF. et al. Platelet Microparticles Enhance the Vasoregenerative Potential of Angiogenic Early Outgrowth Cells After Vascular Injury. Circulation 2010; 122: 495-506.
- 10 Zernecke A. et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Signal 2009; 200: ra81.
- 11 Leroyer AF. et al. Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost 2010; 104: 456-463.
- 12 Xiao Q. et al. The mechanism of stem cell differentiation into smooth muscle cells. Thromb Haemost 2010; 104: 440-448.
- 13 Zernecke A. et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circulation Res 2005; 96: 784-791.
- 14 Hristov M, Weber C. Progenitor cell trafficking in the vascular wall. J Thromb Haemost 2009; 7 (Suppl. 01) 31-34.
- 15 Iwata H, Sata M. Potential contribution of bone marrow-derived precursors to vascular repair and lesion formation: lessons from animal models of vascular diseases. Front Biosci 2007; 12: 4157-4167.
- 16 McDonald OG, Owens GK. Programming smooth muscle plasticity with chromatin dynamics. Circulation Res 2007; 100: 1428-1441.
- 17 Cordes KR. et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009; 460: 705-710.
- 18 Grochot-Przeczek A. et al. Heme oxygenase-1 in neovascularisation: A diabetic perspective. Thromb Haemost 2010; 104: 424-431.
- 19 Idriss NK. et al. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 2008; 52: 971-978.
- 20 Bussolati B. et al. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 2004; 103: 761-766.
- 21 Mause SF, Weber C. Intrusion through the fragile back door: immature plaque microvessels as entry portals for leukocytes and erythrocytes in atherosclerosis. J Am Coll Cardiol 2009; 53: 1528-1531.
- 22 Vanholder R. et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048-1056.
- 23 Lau WL. et al. Phosphate and Vascular Calcification: Emerging Role of the Sodium-Phosphate Cotrans-porter PiT-1. Thromb Haemost 2010; 104: 464-470.
- 24 Cannata-Andia JB. et al. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 2006; 17 (Suppl. 03) S267-S73.